Cargando…
Integrated analysis of the genomic and transcriptional profile of gliomas with isocitrate dehydrogenase-1 and tumor protein 53 mutations
Background: The gene mutation of isocitrate dehydrogenase-1 (IDH1) is commonly found in LGG and some GBM patients and usually carries tumor protein 53 (TP53) mutations. However, the underlying mechanisms on both mutations of glioma patients in IDH1 and TP53 are still unclear. Aim: To find the potent...
Autores principales: | Liu, Han-Qing, Li, Wei-Xin, An, Ya-Wen, Wu, Tao, Jiang, Guang-Yu, Dong, Yu, Chen, Wei-Xin, Wang, Jian-Chun, Wang, Cheng, Song, Shuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669701/ https://www.ncbi.nlm.nih.gov/pubmed/36377597 http://dx.doi.org/10.1177/03946320221139262 |
Ejemplares similares
-
Rapid detection of isocitrate dehydrogenase 1 mutation status in glioma based on Crispr-Cas12a
por: Feng, Zhebin, et al.
Publicado: (2023) -
Ivosidenib in Isocitrate Dehydrogenase 1–Mutated Advanced Glioma
por: Mellinghoff, Ingo K., et al.
Publicado: (2020) -
Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas
por: Li, Ming-Yang, et al.
Publicado: (2015) -
Isocitrate Dehydrogenase Mutations in Glioma: From Basic Discovery to Therapeutics Development
por: Huang, Juan, et al.
Publicado: (2019) -
Isocitrate Dehydrogenase Mutations in Glioma: Genetics, Biochemistry, and Clinical Indications
por: Liu, Yang, et al.
Publicado: (2020)